Human Heredity and Health in Africa (H3Africa): Bioinformatics Network (U41)

The summary for the Human Heredity and Health in Africa (H3Africa): Bioinformatics Network (U41) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Human Heredity and Health in Africa (H3Africa): Bioinformatics Network (U41): The purpose of this FOA is to call for applications to develop an H3Africa Bioinformatics Network by implementing innovative, cost-effective approaches to improving the connectivity among, and overall bioinformatics infrastructure in, all of the components of the H3Africa Consortium, including the H3Africa Collaborative Centers, research projects, and biorepository(ies); to fostering connectivity, interaction and coordination among African research groups working in genomics-based research on human disease and health across the continent; to promoting pan-H3Africa communication; to providing bioinformatics training of several types; to providing services and support to build bioinformatics capacity at African research institutions; to promoting computational skills among African researchers; and to developing new computational tools for genomics research in the African setting.

Federal Grant Title:	Human Heredity and Health in Africa (H3Africa): Bioinformatics Network (U41)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-RM-11-010
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.172
CFDA Descriptions:	Human Genome Research
Current Application Deadline:	Dec 02, 2011
Original Application Deadline:	Dec 02, 2011
Posted Date:	Aug 23, 2011
Creation Date:	Aug 23, 2011
Archive Date:	Jan 02, 2012
Total Program Funding:	$3,100,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); African institutions are eligible for the awards: Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed); • Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed); • NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed); • Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Op...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...